Hedegaard: “We are in talks with the Americans at the moment”
For the second quarter running Bavarian Nordic has raised expectations for the year. The CEO signals continued improvements and remains hopeful about a contract with the US government.
by Stefan Singh Kailay
“It is a good, solid result. We are capable of raising expectations once again. It is primarily driven by the success we see in our production and delivery of the small pox vaccine.”
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
Bavarian-CEO: operational improvements will continue
For abonnenter
US government expands use of Danish vaccine
For abonnenter
Bavarian-CEO: ”Yellow fever, hepatitis, you name it”
For abonnenter
.jpg&w=384&q=75){kind=logo}
